Atlas Trials

Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease

Clinical trial NCT00951834 · COMPLETED

Trial details

NCT number
NCT00951834
Sponsor
Charite University, Berlin, Germany
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2009-10-01
Primary completion
2015-02-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.